UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Akorn, Inc.

(Exact name of registrant as specified in its charter)

 

Louisiana

(State or other jurisdiction of

Incorporation or organization)

72-0717400

(I.R.S. Employer

Identification No.)

  

1925 W. Field Court, Suite 300

Lake Forest, Illinois 60045

(Address of principal executive offices)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Series A Contingent Value Rights   The NASDAQ Global Select Market

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box.

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: None.

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 

 

 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Akorn, Inc. (the “Company”) has filed with the Securities and Exchange Commission (the “Commission”) Amendment No. 1 to the Application for Qualification of Indenture under the Trust Indenture Act of 1939 on Form T-3 (File No. 022-29079) (the “Application”) relating to the securities to be registered hereunder, which was filed on March 16, 2020 and declared effective by the Commission on March 18, 2020.

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The information set forth in the sections captioned “Securities Act Exemption Available” and “Analysis of Indenture Provisions” in the Application is incorporated herein by reference.

 

Item 2. Exhibits.

 

Pursuant to the Instructions as to Exhibits for Form 8-A, the following exhibits are being filed with the Commission in connection with this registration statement.

 

4.1 Contingent Value Rights Agreement, dated as of April 1, 2020, between Akorn, Inc. and American Stock Transfer & Trust Company, LLC.
4.2 Form of Series A Contingent Value Rights (included in Exhibit 4.1).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, each registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  Akorn, inc.
Date:  April 1, 2020 By: /s/ Duane A. Portwood
    Name: Duane A. Portwood
    Title: Chief Financial Officer

 

 

 

 

 

 

 

 

EXHIBIT INDEX

 

4.1 Contingent Value Rights Agreement, dated as of April 1, 2020, between Akorn, Inc. and American Stock Transfer & Trust Company, LLC.
4.2 Form of Series A Contingent Value Rights (included in Exhibit 4.1)

 

 

Akorn (NASDAQ:AKRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Akorn Charts.
Akorn (NASDAQ:AKRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Akorn Charts.